These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 29690653)

  • 1. Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2.
    Peach CJ; Mignone VW; Arruda MA; Alcobia DC; Hill SJ; Kilpatrick LE; Woolard J
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29690653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF-A-stimulated signalling in endothelial cells via a dual receptor tyrosine kinase system is dependent on co-ordinated trafficking and proteolysis.
    Bruns AF; Bao L; Walker JH; Ponnambalam S
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1193-7. PubMed ID: 19909245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-Time Ligand Binding of Fluorescent VEGF-A Isoforms that Discriminate between VEGFR2 and NRP1 in Living Cells.
    Peach CJ; Kilpatrick LE; Friedman-Ohana R; Zimmerman K; Robers MB; Wood KV; Woolard J; Hill SJ
    Cell Chem Biol; 2018 Oct; 25(10):1208-1218.e5. PubMed ID: 30057299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF165b Modulates Endothelial VEGFR1-STAT3 Signaling Pathway and Angiogenesis in Human and Experimental Peripheral Arterial Disease.
    Ganta VC; Choi M; Kutateladze A; Annex BH
    Circ Res; 2017 Jan; 120(2):282-295. PubMed ID: 27974423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF isoforms have differential effects on permeability of human pulmonary microvascular endothelial cells.
    Ourradi K; Blythe T; Jarrett C; Barratt SL; Welsh GI; Millar AB
    Respir Res; 2017 Jun; 18(1):116. PubMed ID: 28578669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A computational analysis of in vivo VEGFR activation by multiple co-expressed ligands.
    Clegg LE; Mac Gabhann F
    PLoS Comput Biol; 2017 Mar; 13(3):e1005445. PubMed ID: 28319199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.
    Zhang Z; Neiva KG; Lingen MW; Ellis LM; Nör JE
    Cell Death Differ; 2010 Mar; 17(3):499-512. PubMed ID: 19834490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic Antiangiogenic Vascular Endothelial Growth Factor-A Splice Variant Revascularizes Ischemic Muscle in Peripheral Artery Disease.
    Raja A; Ganta V
    J Am Heart Assoc; 2024 Oct; 13(20):e034304. PubMed ID: 39392159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endorepellin laminin-like globular 1/2 domains bind Ig3-5 of vascular endothelial growth factor (VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cells.
    Willis CD; Poluzzi C; Mongiat M; Iozzo RV
    FEBS J; 2013 May; 280(10):2271-84. PubMed ID: 23374253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of NanoBiT and NanoBRET to monitor fluorescent VEGF-A binding kinetics to VEGFR2/NRP1 heteromeric complexes in living cells.
    Peach CJ; Kilpatrick LE; Woolard J; Hill SJ
    Br J Pharmacol; 2021 Jun; 178(12):2393-2411. PubMed ID: 33655497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered ratios of pro- and anti-angiogenic VEGF-A variants and pericyte expression of DLL4 disrupt vascular maturation in infantile haemangioma.
    Ye X; Abou-Rayyah Y; Bischoff J; Ritchie A; Sebire NJ; Watts P; Churchill AJ; Bates DO
    J Pathol; 2016 Jun; 239(2):139-51. PubMed ID: 26957058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
    Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
    Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF-A121a binding to Neuropilins - A concept revisited.
    Sarabipour S; Mac Gabhann F
    Cell Adh Migr; 2018 May; 12(3):204-214. PubMed ID: 29095088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling.
    Benedito R; Rocha SF; Woeste M; Zamykal M; Radtke F; Casanovas O; Duarte A; Pytowski B; Adams RH
    Nature; 2012 Mar; 484(7392):110-4. PubMed ID: 22426001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the effects of anti-angiogenic agents targeting specific VEGF isoforms.
    Finley SD; Popel AS
    AAPS J; 2012 Sep; 14(3):500-9. PubMed ID: 22547351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular controls of lymphatic VEGFR3 signaling.
    Deng Y; Zhang X; Simons M
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the ligand-binding properties of fluorescent VEGF-A isoforms to VEGF receptor 2 in living cells and membrane preparations using NanoBRET.
    Peach CJ; Kilpatrick LE; Woolard J; Hill SJ
    Br J Pharmacol; 2019 Sep; 176(17):3220-3235. PubMed ID: 31162634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells.
    Mac Gabhann F; Popel AS
    Am J Physiol Heart Circ Physiol; 2004 Jan; 286(1):H153-64. PubMed ID: 12714333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indolinones and anilinophthalazines differentially target VEGF-A- and basic fibroblast growth factor-mediated responses in primary human endothelial cells.
    Latham AM; Bruns AF; Kankanala J; Johnson AP; Fishwick CW; Homer-Vanniasinkam S; Ponnambalam S
    Br J Pharmacol; 2012 Jan; 165(1):245-59. PubMed ID: 21699503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors.
    Nowak DG; Woolard J; Amin EM; Konopatskaya O; Saleem MA; Churchill AJ; Ladomery MR; Harper SJ; Bates DO
    J Cell Sci; 2008 Oct; 121(Pt 20):3487-95. PubMed ID: 18843117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.